Our dedication to sleep medicine and advancing care for people living with complex and rare conditions, like narcolepsy and idiopathic hypersomnia (IH), has been enhanced by our strong partnerships with patient communities. As a rare disease company with most of our therapeutic areas addressing populations of less than 200,000 patients, we understand these conditions often involve populations even smaller than that, creating a unique dynamic. While awareness of these rare conditions has grown, the journey for patients and caregivers continues to present challenges spanning diagnosis, symptom management and recognizing comorbidities. In fact, many rare disease diagnoses are delayed for years, primarily because most physicians may only see one or two such patients annually, if any.
We believe true progress and meaningful impact stem from collaboration. Partnerships with advocacy groups are essential — they enable us to gain firsthand insights into the daily realities of living with a sleep condition. Advocacy groups also serve as powerful conduits, bringing the authentic patient voice to the forefront, guiding our efforts and ensuring our initiatives truly resonate.
Working side-by-side with advocacy organizations, we’re dedicated to improving comprehensive care and raising awareness about the important link between sleep health and cardiovascular well-being. For example, the American Heart Association recently launched a collaborative initiative with the Sleep Matters Initiative at the Brigham and Women’s Hospital in Boston to examine and address the combined effects of these health risks, with support from Jazz. Recognizing emerging evidence which suggests poor-quality sleep, high sodium intake, and hypertension are more interconnected than previously understood, this initiative aims to raise awareness among clinicians around the interplay between sleep, sodium intake and hypertension and improve cross-disciplinary care.
Yet, our partnerships are more than just collaborations; they’re an extension of our shared vision to help people living with these sleep conditions through increased knowledge and improved access to resources that, ultimately, enable more comprehensive approaches to care. Given the small patient population, we maintain a strong focus on patient findings through our relationships with advocacy groups and leverage unique insights from patient registries. What’s unique about Jazz Pharmaceuticals is how we approach this, how we think differently and index on what’s most important and what will have the greatest impact on patient lives.
By working together with these advocacy groups, we remain steadfast in our dedication to developing life-changing medicines for people with rare diseases—often with limited or no therapeutic options. And this dedication extends to helping ensure that once they’re diagnosed, they get the treatments they need, delivering on our mission to transform the lives of patients.
March is Sleep Awareness Month, and we’re thankful for our partnerships with the sleep community as we look to amplify awareness of the overlooked aspects of life with narcolepsy and idiopathic hypersomnia to help advance care for people living with these conditions.
Jazz Pharmaceuticals, Inc. is proud to support the AHA's Hypertension, Sodium and Sleep Professional Education Initiative.
الإبلاغ عن أثر جانبي
إذا كنت ترغب في الإبلاغ عن أثر جانبي مرتبط بالمنتجات الدوائية لشركة Jazz Pharmaceuticals، يُرجى إرسال بريد إلكتروني إلينا عبر الرابط التالي:
يُرجى تقديم أكبر قدر ممكن من المعلومات المتاحة.
تشمل المعلومات ذات الصلة ما يلي:
بتقديمك لتقريرك وتزويدنا ببيانات الاتصال الخاصة بك، فإنك تُقرّ وتوافق صراحةً على أنه يجوز لقسم السلامة الدوائية المحلي التواصل معك بغرض طلب معلومات إضافية أو توضيحات، إذا اعتُبر ذلك ضروريًا لتقييم التقرير ومتابعته.
يوضح إشعار الخصوصية الخاص بنا المتعلق باليقظة الدوائية والمعلومات الطبية وشكاوى المنتجات كيفية تعامل شركة Jazz Pharmaceuticals مع معالجة المعلومات الشخصية عند التعامل مع تقريرالأثر الجانبي الخاص بك، وهو متاح في مركز الخصوصية لدينا.
Report an Adverse Event
If you want to report a Adverse Event related to Jazz Pharmaceuticals medicinal products, then please send us an e-mail via this link:
Please provide as much available information as possible.
Relevant information includes:
By submitting your report and providing your contact details, you expressly acknowledge and agree that the local drug safety department may contact you for the purpose of requesting additional information or clarifications, should this be deemed necessary for the assessment and follow‑up of the report.
Our Privacy Notice for Pharmacovigilance, Medical Information and Product Complaints outlines how Jazz Pharmaceuticals handles the processing of personal information when dealing with your adverse event report and is available in our Privacy Center.
